Pre-Clinical Toxicity Assessment of Tumor-Targeted Interleukin-12 Low-Intensity Electrogenetherapy

Cancer Gene Therapy - United Kingdom
doi 10.1038/cgt.2010.77
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Genetic Heterogeneity in the Toxicity to Systemic Adenoviral Gene Transfer of Interleukin-12

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2001English

Multilineage Hematopoietic Recovery With Concomitant Antitumor Effects Using Low Dose Interleukin-12 in Myelosuppressed Tumor-Bearing Mice

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2008English

Targeted Toxins for Glioblastoma Multiforme: Pre-Clinical Studies and Clinical Implementation

Anti-Cancer Agents in Medicinal Chemistry
Cancer ResearchMolecular MedicinePharmacology
2011English

Multimodality Imaging in Vivo for Preclinical Assessment of Tumor-Targeted Doxorubicin Nanoparticles

PLoS ONE
Multidisciplinary
2012English

Nanoclustered Cascaded Enzymes for Targeted Tumor Starvation and Deoxygenation-Activated Chemotherapy Without Systemic Toxicity

English

Cardiac Toxicity of HER-2 Targeted Regimens

2019English

Pre-Clinical Assessment of the Potential Intrinsic Hepatotoxicity of Candidate Drugs

2013English

Mechanism of Interleukin 12-Mediated Toxicities During Experimental Viral Infections: Role of Tumor Necrosis Factor and Glucocorticoids

Journal of Experimental Medicine
MedicineAllergyImmunology
1995English

The Toxicology of Interleukin-12: A Review

Toxicologic Pathology
Forensic MedicineToxicologyPathologyCell BiologyMolecular Biology
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy